Mankind Pharma Limited (NSE:MANKIND)
India
· Delayed Price · Currency is INR 2,526.90
+65.10 (2.64%)
May 30, 2025, 10:17 AM IST
Mankind Pharma Revenue
In the fiscal year ending March 31, 2025, Mankind Pharma had annual revenue of 122.07B INR. Mankind Pharma had revenue of 30.79B in the quarter ending March 31, 2025, with 6.43% growth.
Revenue
122.07B
Revenue Growth
+18.12%
P/S Ratio
8.32
Revenue / Employee
6.25M
Employees
19,540
Market Cap
1,015.91B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 271.45B |
| Apollo Hospitals Enterprise | 211.46B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Alkem Laboratories | 127.57B |
| Fortis Healthcare | 77.83B |